A new domain and improved desktop tools are part of Meta’s strategy to win over disillusioned X users and prove Threads’ value to advertisers.
52% of US adults use a VPN to protect their IP address, according to a February 2025 CNET and YouGov survey.
Doing Things, a company of 40 creator-led brands including OverheardLA/NY and Recess Therapy, is ready to evolve from a meme account incubator into a comprehensive media company.
Google’s core businesses remain strong in Q1: Browser scrutiny and AI search shifts could test the foundation of its power
It uses the technology for more manual processes, freeing up the team for creativity.
The BNPL provider is racking up partners in a major expansion push before its now-delayed IPO
The companies faced mixed results and looming uncertainty as a result of tariffs
Madwell sued by NYT for thousands in unpaid debts: The lawsuit serves as a warning and highlights the need for brands to vet the agencies they work with.
Google halts plans to remove third-party cookies in Chrome: The move delays a major privacy shift but doesn’t stop the push for user-centric ad models.
Threads makes ads available globally: The Meta platform benefits from steady growth and a safer brand image than X.
The payments giant also deepened its tie-up with Coinbase to make buying and using the asset more accessible
Design wins power Mobileye’s bullish stance on autonomy’s future: A robust 83% revenue spike and new deals with Volkswagen and Lyft show Mobileye isn’t just surviving the autonomy winter—it’s positioning itself as its comeback story.
Several foreign carmakers saw US sales surge in March: But that momentum is likely to stall given the 25% tariffs on imported vehicles and imported auto parts set to take effect by May 3.
Tariff-related price hikes are coming, CPGs warn: P&G, Keurig Dr Pepper, and Nestlé are among the companies planning to raise prices to offset cost increases.
Chipotle sees pullback in spending tied to consumer unease: Despite those challenges, McDonald’s and Sonic have both found recent success with limited-time promotions.
Big Pharma earnings don’t feel the impact of Trump's current tariffs—yet: Several large pharmas kept yearly financial guidance in place during Q1 earnings calls, highlighting how they’re absorbing current tariff costs. However, major business disruptions will take effect once Trump’s threat of 25% or more pharma tariffs lands.
Younger generations seek out medical advice from social media and their peers: “Doing my own research” is a health trend that took off during the pandemic. Healthcare providers and marketers must point out the dangers of trusting online medical misinformation while being more accessible on digital channels.
Eli Lilly sues telehealth companies over compounded weight loss drugs: Lilly is leaving no stone unturned when it comes to building a legal case to prevent compounded tirzepatide from being prescribed and sold.